Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia

Leuk Lymphoma. 2021 Dec;62(14):3558-3560. doi: 10.1080/10428194.2021.1966787. Epub 2021 Aug 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Imidazoles
  • Niacinamide / analogs & derivatives
  • Philadelphia Chromosome
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Protein Kinase Inhibitors / adverse effects
  • Pyrazoles
  • Pyridazines* / adverse effects

Substances

  • Imidazoles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyridazines
  • asciminib
  • Niacinamide
  • ponatinib
  • Fusion Proteins, bcr-abl